Last reviewed · How we verify
NCT03358446
The Optimal Leg Angulation of Femoral Central Catheterization in Pediatrics
trial testing A group in Pediatric Disorder in 82 participants. Completed in 31 May 2018.
23 March 2018
Quick facts
| Lead sponsor | Samsung Medical Center |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 82 |
| Start date | 11 October 2017 |
| Primary completion | 23 March 2018 |
| Estimated completion | 31 May 2018 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- A group
- S group
Conditions studied
- Pediatric Disorder — all drugs for Pediatric Disorder →
- Femoral Artery Injury — all drugs for Femoral Artery Injury →
- Emergencies — all drugs for Emergencies →
Sponsor
Samsung Medical Center
Who can join
Under 36 Months, any sex, with Pediatric Disorder or Femoral Artery Injury. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Evaluation for the range of smallest leg angulation with femoral artery and vein overlap with femoral central catheterization in pediatrics.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03358446
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pediatric Disorder
Currently open trials in the same condition.
- NCT07267364 — Pelvic Floor Muscle Training and Dynamic Neuromuscular Stabilization Exercises in Pediatric Patients · NA · recruiting
- NCT06554288 — Pharmacogenomic Contributions to Trihexyphenidyl Biotransformation and Response in Children With Dystonic Cerebral Palsy · Phase 1 · recruiting
- NCT06584864 — Bedside Ultrasound on the Effectiveness of Lumbar Puncture in Children. · NA · recruiting
- NCT06464757 — Laryngomalacia, Examinations and Quality of Life in Children Before and After Treatment With Follow-up After 1 Year · recruiting
- NCT05308628 — Pediatric Liver Transplantation-Liver Fibrosis Evaluation by Using Fibrosis Panel · NA · recruiting
Other Samsung Medical Center trials
Trials by the same sponsor.
- NCT07482865 — Routine Versus Provisional Distal Perfusion Catheter Placement in Patients Undergoing Mechanical Circulatory Support · NA · not yet recruiting
- NCT07467213 — Routine Use of Potassium Competitive Acid Blocker vs. Guideline-Directed Gastrointestinal Protection Strategy in Acute M · Phase 4 · not yet recruiting
- NCT07530913 — Effectiveness Analysis of a Rehabilitation Exercise Platform for Living Donor Liver Transplantation Patients · NA · enrolling by invitation
- NCT07500701 — Salvage Moderate Hypofractionated Versus Ultrahypofractionated Radiotherapy for Biochemical Recurrence After Radical Pro · Phase 3 · recruiting
- NCT07409441 — Korea Acute Myocardial Infarction Registry · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03358446 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Samsung Medical Center
- Last refreshed: 19 July 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03358446.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing